Citation tools
"Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats." Journal of Pharmacology and Experimental Therapeutics
368.3
(2019):
524-534.
Web. 18 April. 2024.